Myriam Ben Khelil

4PUBLICATIONS
64CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 20, 2025
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer Immunotherapy.

Myriam Ben Khelil, Maxime Fredon, Nawfel Adib

|Sep 24, 2025
CAR T cell-mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis.

Myriam Ben Khelil, Ahmadreza Arbab, Janesa Srikanthan

|Jun 11, 2025
Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR T-cell Potency.

Laura Marcos-Kovandzic, Michele Avagliano, Myriam Ben Khelil

|Jan 11, 2022
Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy.

Myriam Ben Khelil, Yann Godet, Syrine Abdeljaoued

Pageof 1